SaveHealth reports insulin has revolutionized diabetes care since its discovery, with various types enhancing patient ...
New research shows that the diabetes/obesity medication tirzepatide can cause clinically meaningful improvements in blood ...
A marketing authorization for Zegalogue (dasiglucagon, Zealand Pharma) for the treatment of severe hypoglycemia in patients aged 6 years and older with diabetes has been recommended by the European ...
Insulin type, mixture of insulins in the same syringe, site of injection, and individual patient response differences can all affect the onset, peak, and duration of insulin activity. In general, ...
Despite high use of continuous glucose monitoring and insulin pump therapy, fear of hypoglycemia (low blood sugar) remains a significant barrier to physical activity and exercise for adults with type ...
Children and teenagers who use continuous glucose monitors (CGM) to manage diabetes often fail to use the appropriate alarm settings to alert to dangerously low or harmful high blood sugar levels, ...
Tirzepatide was associated with significant declines in HbA1c and BMI for children and adolescents with type 2 diabetes, according to data from the SURPASS-PEDS trial. Tamara S. Hannon, MD, professor ...